GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 197 filers reported holding GENMAB A/S in Q3 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,936,746 | +42.9% | 54,912 | +54.0% | 0.03% | +41.7% |
| Q2 2023 | $1,355,361 | -8.4% | 35,658 | -9.0% | 0.02% | -14.3% |
| Q1 2023 | $1,479,059 | -24.1% | 39,170 | -14.8% | 0.03% | -30.0% |
| Q4 2022 | $1,949,056 | +20.8% | 45,989 | -8.4% | 0.04% | +11.1% |
| Q3 2022 | $1,614,000 | +47.0% | 50,228 | +65.5% | 0.04% | +89.5% |
| Q1 2022 | $1,098,000 | -23.2% | 30,346 | -16.0% | 0.02% | -24.0% |
| Q4 2021 | $1,429,000 | -13.7% | 36,111 | -4.6% | 0.02% | -16.7% |
| Q3 2021 | $1,655,000 | +57.9% | 37,865 | +47.5% | 0.03% | +50.0% |
| Q2 2021 | $1,048,000 | -18.7% | 25,677 | -19.0% | 0.02% | -35.5% |
| Q4 2020 | $1,289,000 | +14.7% | 31,713 | +3.3% | 0.03% | -8.8% |
| Q3 2020 | $1,124,000 | -4.0% | 30,704 | -11.1% | 0.03% | -15.0% |
| Q2 2020 | $1,171,000 | +109.1% | 34,555 | +37.9% | 0.04% | +166.7% |
| Q4 2019 | $560,000 | – | 25,065 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 52,148 | $1,839,260 | 1.67% |
| Ativo Capital Management LLC | 28,442 | $1,003,132 | 1.13% |
| HARDING LOEVNER LP | 3,204,230 | $113,013,183 | 0.75% |
| Hardman Johnston Global Advisors LLC | 592,318 | $20,891,056 | 0.70% |
| Yorktown Management & Research Co Inc | 16,600 | $585,482 | 0.66% |
| TORRAY INVESTMENT PARTNERS LLC | 104,516 | $3,686,279 | 0.65% |
| First Light Asset Management, LLC | 157,147 | $5,542,575 | 0.53% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 44,300 | $1,561,575 | 0.53% |
| Capricorn Fund Managers Ltd | 37,007 | $1,305,237 | 0.45% |
| Legacy Wealth Asset Management, LLC | 29,496 | $1,040,324 | 0.38% |